Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Venus Concept Gains CE Mark for Venus Versa Pro in EU

EditorEmilio Ghigini
Published 2024-02-22, 07:48 a/m
© Reuters.

TORONTO - Venus Concept Inc. (NASDAQ: NASDAQ:VERO), a prominent medical aesthetic technology company, has announced its receipt of the CE Mark for the Venus Versa Pro system, enabling the company to market this system within the European Union. The certification, awarded by DEKRA Certification B.V., comes after the company's initial commercial launch of the device in the United States on November 1, 2023.

The Venus Versa Pro system represents the latest in fractional skin resurfacing technology from Venus Concept, designed to provide enhanced ablation and coagulation for treating various skin conditions such as acne scars, skin texture issues, and stretch marks. Additionally, the system allows European practitioners to offer Tribella, a comprehensive skin rejuvenation solution.

Dr. Hemanth Varghese, President and Chief Operating Officer of Venus Concept, expressed that the CE Mark reflects the company's dedication to introducing innovative products to the international aesthetic market. The Venus Versa Pro builds upon the Venus Versa system, which boasts over 2,200 installations worldwide. It is a versatile, multi-modal system that encompasses a range of Venus Concept's technologies, aiming to meet the increasing demands of European customers.

The company's forward-looking statements, while indicative of future plans and expectations, are subject to various known and unknown risks and uncertainties. These could significantly impact the company's business operations and financial performance. Venus Concept advises caution in reliance on these projections.

Venus Concept, with a presence in over 60 countries and 12 direct markets, offers a comprehensive portfolio of medical aesthetic and hair restoration technologies. Its range of device platforms includes Venus Versa, Venus Legacy, among others, and hair restoration systems such as NeoGraft and ARTAS iX Robotic Hair Restoration system. The company is supported by healthcare industry investors like EW Healthcare Partners and HealthQuest Capital.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This news is based on a press release statement and reflects the company's latest step in expanding its international reach within the aesthetic technology field.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.